Featuring posts written by the DoseSpot e-Prescribing Integration Team!

Addressing Dentistry’s Role in the Opioid Epidemic

Posted: November 8th, 2016 | Author: | Filed under: Basics, Controlled Substances, Dental | Tags: , , , , , , , , , , , , , , , , , , , | No Comments »

Unfortunately, the opioid epidemic that is currently grappling the United States isn’t exactly news. Headlines appear on a daily basis in regards to this addiction, the overdoses and fatalities, as well as the healthcare community’s contribution to this crisis, both the good and the bad.

We’ve seen Congress, the Surgeon General, and many other organizations make extreme efforts to combat this crisis, yet despite the widespread media attention, many healthcare professionals still don’t realize how dangerous the drugs can be or how addictive they are.

DoseSpot recently conducted a live webinar in an effort to educate and discuss the critical role that dentists in particular play in mitigating the current opioid epidemic that is upon us and during that time, the following crucial points were made:

The blame game needs to stop

Blaming others only diverts the necessary action of collectively coming together as a nation, regardless of one’s associated industry. Healthcare, Law Enforcement, Politics – there needs to be a strong, unified foundation for which we can assemble and fight this battle together.

Break the habit: prescribing patterns of pain medication

Dentists serve a unique role in overcoming this epidemic due to the nature of their work and the procedures they perform, specifically wisdom teeth extraction. It’s a fair statement that the majority do not enter the healthcare industry with ill intent of harming their patients, yet it’s also fair to say that lack of proper education and prior pharmaceutical marketing tactics have fueled poor prescribing patterns. In order to change one’s behavior, programmed thoughts and approaches must be reevaluated.

Opioid addiction does not discriminate

This addiction can affect anyone regardless of one’s socioeconomic status or in some cases, a person’s relationship to their dentist. What DoseSpot coins as “The Insider Threat,” we reveal how certain folks pose a potential risk relative to obtaining controlled substances, both knowingly and secretively. Stories of addiction that are shared during our recent webinar further prove that opioids do not discriminate.

Solutions are available

The truth of the matter is, there is not one single solution that can work independently. It needs to be a collective effort and innovation is critical to success. There needs to be multifaceted solutions to tackle this complex problem ranging from increasing specialty training and education to proper treatment technology, data, and analytics.

To learn more on dentistry’s role in the opioid epidemic, watch the full webinar here.

Presenters:

Greg Waldstreicher, CEO, DoseSpot

Dr. John Zweig, Chief Dental Officer, Dental Associates

Donald Whamond, Chief Technology Officer, Dental Associates

Jason Wolan, Director of EHR Implementation, Great Expressions Dental Centers

Daniel Smelter, Director of Business Analysis, Benevis, Inc.

About DoseSpot

DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.


The Impact of Digital Health on the Ages

Posted: November 1st, 2016 | Author: | Filed under: Basics, Telehealth | Tags: , , , , , , , , , , , , , , , , | No Comments »

Digital Health connecting the dots

How does digital health affect the circle of life?

Today, a patient’s well-being rests in the hands of multiple healthcare professionals, including primary care providers, specialists and surgeons – and sometimes in their own hands with the latest medical devices and technological advances.

In keeping up with this new delivery model, it’s important to understand how people of all ages, pediatric to geriatric, attribute to the nation’s overall population health, its effects on the healthcare system and the United States’ bottom line, while also understanding how technology can play a major role.

This free eBook addresses:

  • The definition of digital health, the current landscape, as well as what’s to come
  • How individuals of all ages affect the health care system and how digital health can help
  • Three health care specialties positioned for digital health growth
  • The role of technology as we shift to value based care
  • Missing pieces of the digital health offering

Download your free copy here!

About DoseSpot

DoseSpot is a Surescripts™ certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.


3 States Laying Down the Law on Opioids

Posted: October 27th, 2016 | Author: | Filed under: Basics, Controlled Substances, In the News, Public Policy, Security, Standards | Tags: , , , , , , , , , , , , , , , , , , | No Comments »

On par with our last post, the widespread media attention and devastating losses associated with our nation’s current opioid epidemic has sparked certain state legislatures to regulate and improve providers’ prescribing habits for prescription painkillers.

With good intentions in tow, some rulings seem to lack readily available solutions that are proven to curb this crisis. However, they do realize that their recent proposals do not mark the end of this uphill battle, rather multifaceted solutions need to be in place to truly, and successfully, overcome this epidemic.

[Read: Overdose Awareness – The Time to Stand Together is Now]

Here are three states that have recently proposed rulings on how opioids should be prescribed:

Vermont

Coined as a “cutting-edge” approach to overcoming the opioid crisis, Governor Peter Schumlin announced proposed limits on the number of opioid medications that could be prescribed.

Like every other state, Vermont has seen an incredible increase in deaths related to opioid and heroin overdose in recent years and Governor Schumlin is no longer sitting on the sidelines.

Earlier this year, he approached both the FDA and pharmaceutical industry in his State of the State address claiming that OxyContin “lit the match that ignited America’s opiate and heroin addiction crisis,” and that the booming American opiate industry knows no shame, an outcry after the FDA approved OxyContin for children a few months ago.

The proposed ruling states that the severity and duration of pain will determine the specific limit for a prescription of opioids. For example, a minor procedure with moderate pain would be limited to 9-12 opioid pills and the amount would increase based on the procedure performed and the level of pain a patient claims. The ruling would also require providers to discuss risks, provide an education sheet to the patient and receive an informed consent for all first-time opioid prescriptions.

The Green Mountain State’s Governor believes that limiting the number of opioid pills prescribed would be an effective way to reduce addiction, yet some folks believe the ruling would only encourage patients to seek illicit drugs elsewhere if they cannot receive pain medication through their provider.

This does make sense considering many former and current heroin abusers have stated that their addiction started from a prescription and when the pill bottle ran out, they were left seeking these drugs on the streets, which have proven to be very, if not more, dangerous than the prescription.

However, the intent of the Governor’s ruling is to prevent addiction from ever happening in the first place. His ruling is specific to cases of acute pain, therefore changing the over-prescribing habits and learned behavior of utilizing opioids as first-line therapy; habits that ensued in large part due to incentives, the surge of pharmaceutical marketing tactics and claims that painkillers were not addictive.

[Read: How Costly Are Prescription Pain Meds?]

New Jersey

With the rate of drug overdose deaths on the rise by 137% since 2000, New Jersey is another state to recently propose new regulations on how and to whom opioids are prescribed.

New Jersey, much like many other states, believes that prevention is key when fighting this crisis and they couldn’t be more correct. Unfortunately, several barriers often occur when seeking appropriate treatment after a patient becomes addicted, (for example, providers are limited to certain amounts for which they can administer reversal drugs), and therefore why not PREVENT addiction, rather than simply TREAT addiction when at many times, it’s too late?

Senator Raymond Lesniak has introduced a bill that would put restrictions on health insurance coverage for opioid medications, while also requiring prescribers to first consider alternative pain-management treatments, follow federal prescribing guidelines and explain the risk of addiction with such substances to their patients before prescribing. Furthermore, providers will need to complete several steps before receiving approval of an opioid prescription. These steps include providing a patient’s medical history, conducting a physical exam and developing an appropriate medical plan for treating a patient’s pain.

While new rulings in place can certainly shift this epidemic, Angela Valente, the executive director of the Partnership for a Drug-Free New Jersey, said it best:

“Awareness and education is the key factor in preventing the abuse of opiates—everyone must have a role in reversing this epidemic, including lawmakers, parents, coaches, educators, and yes, even doctors and dentists.” – Angela Valente

Dr. Andrew Kolodny, executive director of Physicians Responsible for Opioid Prescribing, further backs Valente’s point while also motioning that the medical community has been prescribing too aggressively.

[Read: The Opioid Epidemic: Are Dentists the Black Sheep?]

Pennsylvania

Unfortunately, Pennsylvania experienced 3,500 deaths last year as a result from drug overdose, one of the highest overdose rates in the nation.

The state has had a Prescription Drug Monitoring Program for quite a few years now, however it wasn’t functional until August 2016, when their new program was officially rolled out. Pennsylvania requires providers to query the state’s prescription drug database the first time they prescribe a controlled substance to a patient or if they have reason to believe that the patient is doctor shopping.

Governor Tom Wolf addressed other initiatives underway including requiring providers to query the database EACH time they prescribe opioids, updating medical school curriculum and continuing education, changes to the process of pain care to lower inappropriate use of opioids, and improved screening, referral and treatment for addiction.

What’s bothersome in Pennsylvania, is the method in which these substances have to be prescribed. The Pennsylvania Controlled Substance Act requires narcotic prescriptions to be handwritten on paper prescription pads, yet every other substance can be electronically prescribed. This allows the risk of written prescriptions being lost, stolen, or sold. Luckily, Senator Richard Alloway intends to introduce this measure before the legislative session’s end.

It’s promising to see how the above states are utilizing their state’s Prescription Drug Monitoring Program, or PDMP. All three require their prescribers to query the affiliated state database, however the parameters in which, or how often, they check varies.

While said efforts are better than no effort at all and states are starting to fully understand the need for multifaceted solutions in order to overcome this epidemic, one key solution is missing. E-Prescribing.

[Read: The Link Between PDMP’s and e-Prescribing]

How does e-Prescribing help combat this epidemic?

  • e-Prescribing diminishes the possibilities of duplicate or lost prescriptions since the prescription is sent directly to the patient’s pharmacy
  • A patient will no longer have a paper prescription where the dispense quantity can be altered
  • Prescribers will have access to a patient’s medication history, therefore they can determine if a patient is “doctor shopping” or has a history of substance abuse

To learn how to incorporate e-Prescribing as a solution to the opioid epidemic, schedule a meeting with DoseSpot today.

Sources: NY Times; Boston.com; ABC News; Press of Atlantic City; PennLive

About DoseSpot

DoseSpot is a Surescripts™ certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.


Docity Meets Increasing Patient Demands with Innovative Telehealth Platform and Integration of DoseSpot e-Prescribing Solution

Posted: October 19th, 2016 | Author: | Filed under: Basics, Telehealth | Tags: , , , , , , , , , , , , , , , , , , , | No Comments »

 

NEEDHAM HEIGHTS, MA – Docity, a veteran-owned, connected telehealth platform that enables real time HIPAA-compliant communications between healthcare providers and patients, has announced their strategic, patient-driven integration of DoseSpot’s e-Prescribing solution.

The key component of Docity’s business model is simple: to put patients first by listening to their needs and adapting a digital healthcare system based on those needs.

“Docity’s business is driven solely by the patient-centric model and DoseSpot understood that crucial factor from the very beginning,” said James Cowan, CEO, Docity. “As part of this model, Docity knew that incorporating e-Prescribing was a non-negotiable. E-Prescribing isn’t just a feature; it’s something you must have in today’s competing market.”

Prior to integrating DoseSpot, Docity was offering their connected health platform to several clinics with existing patients, but prescribing was done on the clinician’s own terms. Since the integration with DoseSpot’s e-Prescribing solution, Docity will now be able to offer a comprehensive digital platform to serve the needs of individual patients on a subscription basis.

“The integration process with DoseSpot was a breeze,” Cowan added. “Their team was very flexible and actively engaged, working around the clock to ensure that Docity met al Surescripts certification requirements in a timely manner. Furthermore, they were able to work directly with our developers and their project management tool kept everyone organized which made for a seamless process overall.”

Docity is not only meeting the increasing demands of patients and providers, but the DoseSpot integration has better leveraged relationships with key stakeholders, primarily from a compliance perspective.

“Since integrating with DoseSpot, Docity has seen significant buy-in from highly sought after individuals, providers and companies in the healthcare community who are more eager than ever to stand behind our vision,” said Cowan. “It’s a win-win for both parties.”

“Our partnership with Docity is rooted in understanding and listening to both the patients’ and providers’ demands. Patient-centricity is a current healthcare trend we are committed to upholding as the healthcare landscape continues to evolve,” said Greg Waldstreicher, CEO, DoseSpot. “As a telehealth company, Docity recognized that e-Prescribing is a key component of the value-based delivery model and should be interwoven at the forefront to create a seamless healthcare experience for all involved.”

To learn more about how Docity is meeting the demands of the healthcare community with comprehensive and innovative solutions, please visit www.DoseSpot.com or contact Shauna Leighton, Shauna@DoseSpot.com.

About Docity

Docity Health is a connect health startup headquartered in Chattanooga, TN. Their mission is to connect providers with patients and patients with their health through on demand access to healthcare. For additional information please visit www.Docity.com.

About DoseSpot

DoseSpot is a Surescripts™ certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.


DoseSpot Forecast: 3 Segments Positioned for Telehealth Growth

Posted: October 6th, 2016 | Author: | Filed under: Controlled Substances, Digital Health, Telehealth | Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | No Comments »

It’s no surprise that technology should be considered a key player as we shift to value-based care. With smartphones, tablets and computers, health information is readily available for patients with a simple click of a button. Why should a consultation with a healthcare professional be any different?

Telehealth greatly increases the scope of the healthcare industry and is bound to open huge opportunities in increasing the quality of healthcare. The ultimate goal here, is to prevent hospital readmissions through better management of individuals with chronic conditions, while also reducing associated costs. By enabling remote patient monitoring and remote access to clinicians, market growth is inevitable as awareness and implementation of standards for reimbursement and adoptions of these care models expands.

While several reports claim that “technology gets in the way of the patient experience,” patients are in fact the ones demanding such access to care. This increase in patient demand for telehealth services has prompted many companies and healthcare organizations to think outside of the box and reevaluate the patient-centric model, while questioning what that care model really means to a patient.

Well, it’s simple. Patients want a customized, cost-effective and convenient healthcare experience to which telehealth can provide.

A recent report states that the global telehealth market was valued at $14.3 Billion in 2014 and is estimated to reach $36.3 Billion by 2020, growing at a CAGR of 14.30% from 2014 to 2020.

With these numbers in tow, we predict the most growth in three different segments:

Behavioral Health and Addiction

As mentioned in a previous post, telehealth has the ability to bridge the gaps in care of behavioral health patients and providers. Not only does it provide a convenient, more comfortable and less expensive medical consultation, but it broadens accessibility to patients whom may not have many options when seeking a behavioral health provider, especially in rural areas. Unfortunately, the lack of psychiatrists and addiction specialists across the nation, as well as the stigma often involved, are contributing to the mental health and addiction issues and creating barriers to appropriate care.

Patients will see their primary care physician and may not receive the exact treatment plan that they need; after all, primary care physicians do not specialize in behavioral health or addiction and often, these illnesses require a lot of time and patience to which the physician may not be able to accommodate. Telehealth will be able to connect patients in need with specialists regardless of their location who know how to treat these specific health issues.

This effective care model will not only lessen the hit on the nation’s bottom line as more and more individuals grapple with suicide, addiction, and other mental health issues, but also revolutionize the way people view the stigma involved and encourage patients to seek help as they are able to receive treatment from the comfort of their own home.

Geriatric Care

Geriatric patients stand to benefit tremendously as a digital health consumer. As mobility can be especially difficult for these patients, the ability to see a physician remotely removes one of the largest barriers to care. Furthermore, transporting patients of this age may potentially do more harm than good.

With telemedicine, providers can more quickly spot at-risk patients and provide interventions to avoid an otherwise unnecessary hospital admission. Similarly, nursing homes can partner with health systems to provide bedside care for their residents at a fraction of the price of an onsite physician.

These infrastructure synergies provide connectivity with electronic health records (EHRs) and create clear communication among hospitals, senior care facilities, referring physicians and patient families. They also provide the link to population based management databases and other health care analytic functions to measure value.

Surgery

Many surgical departments find telehealth to be a more convenient and cost-effective way for pre- and post- operative instructions for procedures of all magnitudes including wisdom teeth extraction, colonoscopies, stent placement and more.

With in-person visits and paper instructions, patients may misinterpret or even forget important information relative to their surgery. This includes what medications to stop taking and how to physically prepare for surgery, while providing a clear, direct line of answers for any questions a patient may have. With instructions digitally delivered prior to surgery, telehealth reduces patient no shows and saves valuable scheduled operating room time.

For post-op patients, providers can check the patient visually, ensuring that patients are following their treatment plans and making adjustments as needed. Through this continuous connection, providers are empowered to deliver the guidance that many patients need as they go through the healing process. These virtual check-ins ensure the patient is on the road to recovery, thus reducing readmission rates all without the patient ever having to leave their home.

Furthermore, telehealth can improve treatment and medication compliance, specifically with controlled substances, i.e. pain medication. Opioid addiction often begins at the hands of a prescriber and with the nation currently facing an opioid epidemic, marrying technology and follow-up appointments when prescribing these types of medications serves as the optimal solution for the safety of all involved.

Technology should no longer be viewed as a barrier to care, but rather embraced in order to improve the healthcare industry, including the improvement of interoperability as well as patient outcomes. Telehealth not only meets the ever increasing demands of patients, but it also assists in preventative care by creating greater access to such care, thus reducing down-the-road costs and burdensome associated with chronic disease. With many chronic diseases being completely preventable, the prevent vs. treat mantra should be sound in every healthcare professional’s mind, while realizing that telehealth is a seamless way of delivering healthcare for all involved.

There may currently be barriers in place regarding reimbursement from payers, but that’s sure to change as more and more payers jump on board for this new delivery model. After all, who’s to say telehealth won’t become the norm and be known as simply….health?

Sources: American Well; OpenPR; mHealth Intelligence; Healthcare IT News

About DoseSpot

DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.


The Uber of Healthcare…No, Really.

Posted: September 29th, 2016 | Author: | Filed under: Basics, In the News | Tags: , , , , , , , , , , , , , , , , , , | No Comments »

As the healthcare industry shifts to a value-based care delivery model, that is, the value equivalent to patient outcomes over cost, more and more initiatives are being introduced as a way to combat the ever-increasing wasted costs our healthcare system experiences. This includes efforts to reduce hospital readmissions, better manage pharmacy drug spend and medication adherence, and broaden access to care, especially for the elderly, disabled and low-income patients.

While many programs are in place to provide services for the above mentioned, one may not realize how transportation costs are attributing to the rising healthcare spend. One may also not view Uber as an innovative solution for reducing such costs, however the company, partnered with Circulation, has recently announced a HIPAA compliant pilot program with certain hospitals that will provide non-emergency medical transportation in urban areas within Massachusetts, Pennsylvania and Delaware.

Why does this matter?

In a given year, 3.6 Million Americans, including almost one million children, will miss doctor’s appointments due to a lack of transportation or one’s inability to drive, resulting in wasted spend for the healthcare system. More specifically, Medicaid spends $3 Billion per year on non-emergency medical transportation, with a third of those payments being deemed inappropriate.

How does it work?

Circulation is integrated with existing and on-demand secure healthcare information systems that schedules non-emergency medical rides that are affordable and tailored for patients’ specific needs such as wheelchair accessibility. Patients do not even need to utilize the Uber mobile app or own a smartphone. They can simply call to schedule their pick-up time and after dispatch confirms their eligibility and transport authorization, they will receive a text, call or email confirming the driver’s estimated pick-up time and description of the vehicle to which they are then safely driven to and from their destination.

Research thus far has proven to reduce wait times for transportation by almost 30 percent and cut costs by almost a third, while boasting patient satisfaction at 80 percent.

Uber and Circulation provide more than just a ride – they are creating a seamless experience for patients, providers and hospital staff all from one convenient interface and in real-time. The system not only allows the scheduling of transportation, but also notifies providers when a patient has arrived for their appointment.

With the current unmodernized healthcare transportation system in place, this program proves to be an innovative step in the right direction.

Sources: Business Wire; HealthcareIT News; Circulation; JAMA

Photo Credit: Google Play

About DoseSpot

DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit http://www.DoseSpot.com.


3 Takeaways from Boston’s Opioid Summit and Hack-a-Thon

Posted: September 15th, 2016 | Author: | Filed under: Basics, Controlled Substances, Public Policy | Tags: , , , , , , , , | No Comments »

Recently, DoseSpot was fortunate to attend Boston’s first ever opioid epidemic hack-a-thon to hear from key opinion leaders in an effort to pitch solutions on how to combat the country’s rising opioid epidemic. Sponsored by the GE Foundation and Massachusetts General Hospital (MGH), the event was comprised of like-minded individuals from all walks of life and specialties, many whom normally wouldn’t sit side by side in the same room until this specific event brought them together. Attendees were given the opportunity to innovate, think differently about this issue and further realize that a significant change is needed in order to tackle this fatal crisis currently grappling our nation.

After attending the summit, the message was clear: we can no longer sit back and believe that there is a one-stop solution. Collective efforts must be put in place and educating and incorporating all components of the healthcare system is imperative to its success.

Here are DoseSpot’s 3 takeaways from the summit:

Opioid addiction does not discriminate

Athletes, politicians, police officers, clinicians, mothers, fathers, siblings, children. Regardless of one’s socioeconomic status, opioid abuse and addiction can affect anyone. In MA alone, there are 4 deaths per day due to opioid overdose and in 2012 there were enough opioid prescriptions to give every American adult their own bottle of pills. However, beyond these statistics are the stories and these courageous stories rang loudly throughout the entire event.

Treat opioid addiction just like any other chronic illness

The stigma associated with addiction often deters people from receiving the treatment they need, and worse, sometimes that stigma is put in place by the very people meant to help them. As many of the speakers at the summit expressed, overcoming stigma should be of utmost priority and addiction should be treated in an effective, mainstream way just like any other condition. Addiction is not a choice; it is a disease.

There needs to be multifaceted solutions to tackle this complex problem

One panelist pointed out that the nation is not thinking big enough or differently enough. Clinicians and healthcare professionals may have blinders on when treating patients, but “one size does not fit all” should be the mantra that everyone utilizes when evaluating their treatment approach. A provider shouldn’t refer to themselves as a one treatment option provider, but utilize all best practices available. As Governor Baker asked, “Wouldn’t you be a better clinician if you expanded your knowledge through a variety of options and techniques?” This includes big data, analytics, e-Prescribing, Medication Assisted Therapy (MAT) and much, much more.

Sources: WBUR; Boston Globe; The Daily Free Press; Boston Business Journal

About DoseSpot

DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.


Digital Health Clinic Maven Integrates DoseSpot e-Prescribing

Posted: June 2nd, 2015 | Author: | Filed under: Basics, In the News, Newsletter, Telehealth | Tags: , , , , , , , | No Comments »

Needham Heights, MA (PRWEB) June 02, 2015

DoseSpot, an industry leader in e-Prescribing integration platforms for medical, dental and telehealth software, today announced that Maven, a digital health clinic designed exclusively for women, has completed Surescripts certification through DoseSpot.

Maven offers on demand video appointments directly to women seeking customized care for health and wellness, prenatal care, postpartum care and family care. Maven has hundreds of medical professionals available at the click of a button and through the DoseSpot integration, Maven’s prescribers can e-Prescribe to more than 65,000 pharmacies nationwide.

Maven opted to completely customize the look and feel of the DoseSpot user interface by tailoring the DoseSpot provided cascading style sheets (CSS). This allowed Maven to quickly match the DoseSpot and Maven user interfaces for a seamless e-Prescribing experience. “DoseSpot customers have the ability to completely white label our e-Prescribing solution”, said Greg Waldstreicher, CEO, DoseSpot. “And we have really enjoyed working with Maven to customize their DoseSpot CSS for mobile optimization as their patients and prescribers conduct video appointments on mobile devices.”

Through the DoseSpot integration, Maven prescribers are now able to route prescriptions electronically to the patient’s pharmacy of choice for the patient to then pick up. This workflow saves all parties involved a substantial amount of time as the patient does not need to travel to the prescriber’s office and the prescriber no longer needs to call the pharmacy. The telehealth care model is entirely focused around efficiency and the DoseSpot e-Prescribing integration further fuels increased efficiencies for the patient, prescriber and pharmacy.

“At Maven our mission is to support women by giving them instant access to healthcare. Sometimes this involves a prescription for medication. Our partnership with DoseSpot has enabled our network of doctors, midwives, and nurse practitioners to write prescriptions quickly, safely, and seamlessly,” said Katherine Ryder, Founder and CEO of Maven.

For more information on e-Prescribing Integration platforms and DoseSpot, please visit http://www.DoseSpot.com or contact Lindsay Walsh, Lindsay(at)dosespot(dot)com.

About Maven 
Maven is a digital clinic for women. Get your health questions answered by doctors, nurse practitioners, OB/GYNs, lactation consultants, doulas, mental health specialists, physical therapists and nutritionists via video appointments and free forums. For more information, please visit http://www.MavenClinic.com.

About DoseSpot 
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit http://www.DoseSpot.com.

Read the full press release here: http://www.prweb.com/releases/2015/06/prweb12760396.htm


XLDent Completes EPCS Certification with DoseSpot’s Dental e-Prescribing Platform

Posted: February 19th, 2015 | Author: | Filed under: Basics, Controlled Substances, Dental, In the News, Standards | Tags: , , , , , , | No Comments »

Needham Heights, MA (PRWEB) February 19, 2015

DoseSpot, an industry leader in e-Prescribing integration platforms for medical, dental and telehealth software, today announced that Professional Economics Bureau of America’s XLDent has successfully integrated DoseSpot’s EPCS certified module for Electronic Prescribing of Controlled Substances (EPCS). In addition, XLDent successfully completed an EPCS integration review by Drummond Group and XLDent’s dental customers are now equipped to e-Prescribe controlled substances in 49 states.

“Following DoseSpot’s successful completion of EPCS certification last year, we are thrilled to be working with our existing customer base to provide EPCS capabilities within our easy-to-use prescribing interface” said Greg Waldstreicher, CEO, DoseSpot. The certification comes in advance of the New York state mandate whereby all prescriptions must be sent electronically including controlled substances. The mandate goes into effect March 27, 2015 and will have a major impact on the dental industry as dental providers are most frequently prescribing a combination of antibiotics and controlled substances.

The DoseSpot Dental platform integrated with XLDent offers dentists the ability to route e-Prescriptions to the patient’s pharmacy of choice after automatically checking for any drug-drug and drug-allergy interactions. “With the NY mandate on the horizon and recent reclassification of hydrocodone combination medications, it’s critical for dental providers to adopt an e-Prescribing solution capable of sending all prescriptions electronically” added Greg. “XLDent continues to be at the forefront of dental e-Prescribing and we’re excited to see what the future has in store for e-Prescribing in dentistry.”

“XLDent partnered with DoseSpot in 2011 to offer integrated e-Prescribing services when it was mandated by the state of Minnesota and now we’re excited to be one of the first dental software solutions to integrate EPCS capabilities into our Dental Practice Management and Electronic Dental Record offering” said Dawn Christodoulou, President, Professional Economics Bureau of America, Inc. “It continues to be a pleasure to work with DoseSpot, a company that shares in our vision to bring valuable, patient-centered solutions to the table.”

For more information on DoseSpot’s EPCS software, please visit http://www.DoseSpot.com or contact Lindsay Walsh, Lindsay(at)dosespot(dot)com.

About XLDent 
The XLDent dental practice management system takes advantage of the latest in software development and design tools to provide its clients with the most intuitive, robust, easy-to-use dental program available. XLDent is an electronic dental records system that automates key business processes and ensures dental teams have the tools they need to manage the practice more profitably. Key benefits include a comprehensive suite of products written for a mobile, wireless, tablet PC environment. Other key benefits include seamlessly integrated e-Prescribing through DoseSpot, flexible Progress Note system, efficient clinical workflows, and dentist and Patient Portals. XLDent supports general and specialty dental clinics and is used by single practitioners as well as large multi-dentist, multi-location clinics nationwide.

About DoseSpot 
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit http://www.DoseSpot.com.

Read the full press release here: http://www.prweb.com/releases/2015/02/prweb12528541.htm


DoseSpot Completes Electronic Prescribing of Controlled Substances Certification with Drummond Group

Posted: October 15th, 2014 | Author: | Filed under: Controlled Substances, In the News, Newsletter, Public Policy, Security, Standards | Tags: , , , , , , | No Comments »

Needham Heights, MA (PRWEB) October 15, 2014 – DoseSpot, an industry leader in e-Prescribing integration platforms for medical, dental and telehealth software, today announced that its software application has completed the required third-party Electronic Prescribing of Controlled Substances (EPCS) audit with Drummond Group Inc., a global software test and certification body that was approved by the Drug Enforcement Administration (DEA) to audit EPCS software applications.

DoseSpot selectively pursued EPCS Certification with Drummond Group, one of the first DEA approved certification bodies. “After undergoing Drummond Group’s extensive audit process and phased approach to understanding the EPCS requirements, DoseSpot may now deliver audited and trusted EPCS software to their customers,” said Aaron Gomez, Drummond Group’s Director of EPCS Auditing.

The audited EPCS software also incorporates industry leading two-factor authentication and identity proofing technologies to meet the requirements of the DEA Interim Final Rule for EPCS. “We strive to provide an easy-to-use e-Prescribing interface and our team has successfully incorporated the EPCS functionality without disrupting our existing user experience,” said Greg Waldstreicher, President, DoseSpot.

DoseSpot prescribers will now have the ability to e-Prescribe controlled substances in 49 states. “In less than six months, New York will be the first state to mandate e-Prescribing, including EPCS,” added Greg Waldstreicher. “We are committed to offering the best e-Prescribing integration experience for our current and future software customers and have made the process for enabling EPCS incredibly easy.”

For more information on DoseSpot’s EPCS software, please visit http://www.DoseSpot.com or contact Lindsay Walsh, Lindsay(at)dosespot(dot)com.

About DoseSpot 
DoseSpot is a Surescripts™ certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. To request a demo of DoseSpot’s e-Prescribing integration platforms, please visit http://www.DoseSpot.com/.

About Drummond Group Inc. 
Drummond Group Inc. is a global software test and certification lab and third-party auditor that serves a wide range of vertical industries. In healthcare, Drummond Group tests and certifies Controlled Substance Ordering Systems (CSOS), Electronic Prescription of Controlled Substances (EPCS) software and processes, and Electronic Health Records (EHRs) – designating the trusted test lab as the only third-party certifier/auditor of all three initiatives designed to move the industry toward a digital future. Founded in 1999, and accredited for the Office of the National Coordinator HIT Certification Program as an Authorized Certification Body (ACB) and an Authorized Test Lab (ATL), Drummond Group continues to build upon its deep experience and expertise necessary to deliver reliable and cost-effective services. For more information, please visit http://www.drummondgroup.com or email DGI(at)drummondgroup(dot)com.

Read the full press release here: http://www.prweb.com/releases/2014/10/prweb12249755.htm